Ausania Fabio, Cook Natalie, Jamieson Neville, Huguet Emanuel, Jah Asif, Praseedom Raaj
Hepato-Pancreato-Biliary Surgery, Addenbrooke's Hospital, NIHR Comprehensive Biomedical Research Centre, Cambridge, United Kingdom.
JOP. 2010 May 5;11(3):226-9.
Pancreatic leak following pancreaticoduodenectomy has a major impact on postoperative mortality. However, it is not clear whether pancreatic leaks affect long term survival in patients with pancreatic ductal adenocarcinoma.
The aim of this study is to compare the long term outcome in patients who underwent pancreaticoduodenectomy, with and without postoperative pancreatic leak.
All 133 patients who underwent a pancreaticoduodenectomy at the HepatoPancreatoBiliary Unit, Addenbrooke's Hospital, Cambridge, between June 2002 and June 2007 were identified from a prospectively held database. The study was restricted to 47 patients who had a confirmed diagnosis of pancreatic ductal adenocarcinoma.
Pancreatic leak was defined as drain fluid amylase more than three times the serum level for more than 3 days post operatively.
Long term survival of patients with and without leaks were compared using Kaplan-Meier curves and significance was measured using the log-rank test.
Median follow-up was 30.8 months. The median actuarial survival of all ductal adenocarcinoma patients was 19 months. Pancreatic leaks occurred in 9 patients (19.1%). There were no significant differences in the overall survival or presence of recurrence between the two groups.
Pancreatic leak following pancreaticoduodenectomy does not appear to impact on long-term outcome of patients with pancreatic ductal adenocarcinoma.
胰十二指肠切除术后胰瘘对术后死亡率有重大影响。然而,尚不清楚胰瘘是否会影响胰腺导管腺癌患者的长期生存。
本研究旨在比较接受胰十二指肠切除术且有或无术后胰瘘患者的长期预后。
从一个前瞻性数据库中识别出2002年6月至2007年6月期间在剑桥阿登布鲁克医院肝胆胰科接受胰十二指肠切除术的所有133例患者。该研究仅限于47例确诊为胰腺导管腺癌的患者。
胰瘘定义为术后3天以上引流液淀粉酶超过血清水平3倍。
使用Kaplan-Meier曲线比较有或无胰瘘患者的长期生存情况,并使用对数秩检验测量显著性。
中位随访时间为30.8个月。所有导管腺癌患者的中位精算生存时间为19个月。9例患者(19.1%)发生胰瘘。两组患者的总生存率或复发情况无显著差异。
胰十二指肠切除术后的胰瘘似乎不会影响胰腺导管腺癌患者的长期预后。